The ongoing outbreak of the coronavirus infection has killed more than 2 million people. Herein, we demonstrate that Rhodamine 6G (Rh-6G) dye conjugated DNA aptamer-attached gold nanostar (GNS)-based distance-dependent nanoparticle surface energy transfer (NSET) spectroscopy has the capability of rapid diagnosis of specific SARS-CoV-2 spike recombinant antigen or SARS-CoV-2 spike protein pseudotyped baculovirus within 10 min. Because Rh-6G-attached single-stand DNA aptamer wrapped the GNS, 99% dye fluorescence was quenched because of the NSET process. In the presence of spike antigen or virus, the fluorescence signal persists because of the aptamer-spike protein binding. Specifically, the limit of detection for the NSET assay has been determined to be 130 fg/mL for antigen and 8 particles/mL for virus. Finally, we have demonstrated that DNA aptamer-attached GNSs can stop virus infection by blocking the angiotensin-converting enzyme 2 (ACE2) receptor binding capability and destroying the lipid membrane of the virus.
The ongoing outbreak of the coronavirus infection has killed more than 2 million people. Herein, we demonstrate that Rhodamine 6G (Rh-6G) dye conjugated DNA aptamer-attached gold nanostar (GNS)-based distance-dependent nanoparticle surface energy transfer (NSET) spectroscopy has the capability of rapid diagnosis of specific SARS-CoV-2spike recombinant antigen or SARS-CoV-2spike protein pseudotyped baculovirus within 10 min. Because Rh-6G-attached single-stand DNA aptamer wrapped the GNS, 99% dye fluorescence was quenched because of the NSET process. In the presence of spike antigen or virus, the fluorescence signal persists because of the aptamer-spike protein binding. Specifically, the limit of detection for the NSET assay has been determined to be 130 fg/mL for antigen and 8 particles/mL for virus. Finally, we have demonstrated that DNA aptamer-attached GNSs can stop virus infection by blocking the angiotensin-converting enzyme 2 (ACE2) receptor binding capability and destroying the lipid membrane of the virus.
The respiratory syndrome coronavirus-2
(SARS-CoV-2) epidemic has spread worldwide very rapidly, and it threatens
the world economy, health, and social life.[1−10] As per the world health organization (WHO), more than 106 million
people around the world have suffered the effects of the coronavirus
disease of 2019 (COVID-19), and around 2.3 million have died worldwide.[1−5] For any disease, the immediate requirement is a fast and effective
diagnostic of the virus, which is the key to prevent infection in
the society.[5−15] In the current Letter, we report that spike protein-specific aptamer-attached
gold nanostars (GNSs) can be used for rapid diagnosis of specific
SARS-CoV-2spike recombinant antigen or virus itself via a distance-dependent nanoparticle surface energy transfer (NSET)
process.[16−22]Because gold nanoparticles exhibit 9–10 orders of magnitude
higher quenching efficiency than typical small molecule dye–quencher
pairs,[16−24] NSET spectroscopy using GNSs has the capability to be used as a
biophysical tools beyond Förster resonance energy transfer
(FRET).[16−22] It is now well-documented that because gold nanostars exhibit very
high extinction coefficient, single GNS-based optical nanoprobes are
comparable with an optical organic probe made with more than 106 dye molecules together.[16−27] Recent published data indicate that the receptor-binding domain
(RBD) of the SARS-CoV-2spike glycoprotein (S protein) is responsible
for virus entry and disease pathogenesis.[3−15] Therefore, we have used spike protein-specific aptamer-attached
GNSs for specific diagnosis and effective inhibition of the virus.
As shown in Figure A, in the absence of spike protein, Rh-6G attached to single stand
(ss) DNA aptamer-wrapped gold nanoparticle. Because of the above fact,
the fluorescence signal from the Rh-6G dye is quenched by GNS via the NSET process. In contrast, as shown in Figure B,C, when SARS-CoV-2
antigen or virus particles are added, because of the aptamer–spike
protein binding, the distance between the GNS and dye increases, and
as a result, the fluorescence signal persists. We have used the observed
NSET signal change in the absence or presence of antigen or virus
for the detection purpose. Reported data show that spike protein-specific
aptamer-attached GNS-based NSET can be used for the diagnosis of COVID-19spike antigen at 130 fg/mL concentration level and virus at 8 particles/mL
level.
Figure 1
(A) Schematic representation of the design criteria for Rh-6G conjugated
DNA aptamer-attached gold nanostar (GNS)-based NSET. Because of the
wrapping of ss-DNA on GNS, the NSET occurs between GNA and Rh-6G.
(B) Scheme showing that spike protein-specific ss DNA aptamer binds
with COVID-19 antigen, which allows DNA to be unwrapped from GNS.
(C) Scheme showing that spike protein-specific DNA binds with SARS-CoV-2
spike protein pseudotyped baculovirus, which allows ss DNA to be unwrapped
from GNS.
(A) Schematic representation of the design criteria for Rh-6G conjugated
DNA aptamer-attached gold nanostar (GNS)-based NSET. Because of the
wrapping of ss-DNA on GNS, the NSET occurs between GNA and Rh-6G.
(B) Scheme showing that spike protein-specific ss DNA aptamer binds
with COVID-19 antigen, which allows DNA to be unwrapped from GNS.
(C) Scheme showing that spike protein-specific DNA binds with SARS-CoV-2spike protein pseudotyped baculovirus, which allows ss DNA to be unwrapped
from GNS.For the detection and inactivation,
SARS-CoV-2spike protein pseudotyped
baculovirus has been used.[27,28] Because the S protein
of the virus and host angiotensin-converting enzyme 2 (ACE2) binding
is the key for infection spread, we have used aptamer-attached GNSs
as an inhibitor for blocking virus spread.[8−15,27−30] In the current Letter, we demonstrate
that the spike protein-specific DNA aptamer-attached GNSs (without
Rh-6G) can be used to block the viral entry into cells. For this purpose,
we have used ACE2 expressing HEK293T cell line.[27,28] Reported scanning and transmission electron microscopy and fluorescence
microscopy data show that spike protein-specific DNA aptamer-attached
GNSs can be used to stop the spread of the virus.For the design
of Rh-6G conjugated ss-DNA aptamer-attached GNS,
which is specific for binding with spike protein, we have used 5′-ATCCAGAGTGACGCAGCATTTCATCGGGTCCAAAAGGGGCTGCTCGGGATTGCGGATATGGACACGT-3′,
DNA aptamer which has been reported recently to be specific for the
SARS-CoV-2spike glycoprotein.[12] As shown
in the Figure A, ss-DNA
(HS–(CH2)6–3′-oligo-5′-Rh-6G)
was attached to GNS via thiol-gold chemistry, as
we and others have reported before.[16−22] For this purpose, initially we have synthesized GNS using silver
assisted seedless growth method in the presence of HEPES buffer.[23−25] We report the synthesis details in the Supporting Information. After that, GNSs were characterized by UV–vis
spectroscopy and TEM as reported in Figure S1A,B in the Supporting Information.TEM data show that for GNS
particles the spherical core diameter
is around 15 ± 3 and branch length is around 12 ± 4 nm.
The extinction spectra show that freshly prepared GNSs exhibit strong
plasmon band with λmax ≈ 560 nm.[23] In the next step, ssDNA (HS–(CH2)6–Oligo-Rh-6G) aptamer was attached to GNS via thiol-gold chemistry. We have reported the synthesis
details in the Supporting Information.
Next, to determine how many aptamers are bound to GNS, we have separated
aptamer from GNS by dissolving nanostar in 10 μM potassium cyanide.
In the next step, from fluorescence recovery intensity measurement,
we have found out that around 60–80 aptamers are attached to
each GNS.As reported in Figure S1C in the Supporting
Information and Figure A, the fluorescence signal from the Rh-6G-attached aptamer is totally
quenched when it has been attached to a GNS. As shown in Figure A, when a Rh-6G conjugated
ss DNA aptamer is attached to GNS surface via -SH
linkage, the 5′-Rh-6G ends of ss DNA loop back onto the GNS
surface.[16−22] In this condition, strong NSET[16−22] occurs between dye donor and GNS acceptor, which provided 99% of
quenching efficiency, as reported in Figure A. As we and others have reported before,
when Rh-6G is placed at a short distance on GNSs, which possesses
a strong plasmon field, the electrons of Rh-6G participating in the
excitation/emission process will interact with the field.[16−22] As a result, we have observed strong NSET, and it is because each
GNS has the capability to be used as an excellent quencher, which
is equivalent to several million dye molecules.[16−22] To understand whether in the Rh-6G conjugated ss (single strand)
DNA aptamer GNS surface, 5′-Rh-6G ends of ss DNA can loop back
onto GNS, we have added complementary DNA which will form a double
helix structure.
Figure 2
(A) Fluorescence spectra from Rh-6G conjugated spike protein-specific
DNA aptamer-attached GNS in the absence of antigen and presence of
SARS-CoV-2 spike recombinant antigen (10 pg/mL), flu virus antigen
(100 pg/mL), and rotavirus antigen (100 pg/mL). The ratio of DNA aptamer
and COVID-19 antigen was kept as 1:1. (B) Plot showing how SERS intensity
from Rh-6G conjugated DNA aptamer-attached GNS varies with the addition
of antigen. The ratio of DNA aptamer and COVID-19 antigen was kept
as 1:1. (C) Fluorescence spectra from Rh-6G conjugated spike protein-specific
DNA aptamer-attached GNS in the presence of SARS-CoV-2 spike recombinant
antigen (10 pg/mL), flu virus antigen (100 pg/mL), and rotavirus antigen
(100 pg/mL). (C) Plot indicating the variation of log of (NSET intensity
change due to the addition of spike recombinant antigen) with the
log of (amount of spike recombinant antigen).
(A) Fluorescence spectra from Rh-6G conjugated spike protein-specific
DNA aptamer-attached GNS in the absence of antigen and presence of
SARS-CoV-2spike recombinant antigen (10 pg/mL), flu virus antigen
(100 pg/mL), and rotavirus antigen (100 pg/mL). The ratio of DNA aptamer
and COVID-19 antigen was kept as 1:1. (B) Plot showing how SERS intensity
from Rh-6G conjugated DNA aptamer-attached GNS varies with the addition
of antigen. The ratio of DNA aptamer and COVID-19 antigen was kept
as 1:1. (C) Fluorescence spectra from Rh-6G conjugated spike protein-specific
DNA aptamer-attached GNS in the presence of SARS-CoV-2spike recombinant
antigen (10 pg/mL), flu virus antigen (100 pg/mL), and rotavirus antigen
(100 pg/mL). (C) Plot indicating the variation of log of (NSET intensity
change due to the addition of spike recombinant antigen) with the
log of (amount of spike recombinant antigen).Because -ds (double stand) DNA is not conformationally flexible
for bending, 5′-Rh-6G ends of -ds DNA cannot loop back onto
GNSs. Because of this fact, the distance between GNS and Rh-6G dye
increases. As a result, we have observed high fluorescence after the
formation of -ds DNA, as reported in Figure S1E in the Supporting Information. The above experimental data is clear
evidence that in ss DNA aptamer, the rhodamine 6G at the 3′
end can loop back onto the GNS surface.To understand better
whether 5′-Rh-6G ends of ss DNA aptamers
are adsorbed onto the GNS surface, a surface enhanced Raman intensity
(SERS) enhancement experiment has been explored.[23−25] As reported
in Figure B, excellent
SERS intensity enhancement has been observed. The observed Raman mode
from Rh-6G-attached ss DNA aptamers is N–C–C bending
mode of the ethylamine group at 376 cm–1, as we
and others reported before.[23−25] Similarly, we have also observed
Raman modes due to the bending of the C–C–C ring at
615 cm–1 and C–H out-of-plane at 778 cm–1, as we and others reported before.[23−25] From the observed
Raman modes, we have estimated that the Raman enhancement factor is
∼3.68 × 107, which clearly indicates that the
5′-Rh-6G ends of ss DNA aptamers are adsorbed onto the GNS
surface.As shown in Figure B, because of the antigen–aptamer binding, the
distance between
GNS and Rh-6G dye increases when coronavirus antigens are added to
spike protein-specific ss DNA conjugated GNS. As a result, fluorescence
signal persists as reported in Figure S1D in the Supporting Information and in Figure C. The observed NSET intensity change in
the presence of specific antigen has been used for detection purposes.
It is now well-documented that aptamers are capable of binding with
antigen protein via noncovalent interaction, such
as hydrogen bonding, van der Waals forces, and other interactions.[11,12] Recently reported molecular dynamics simulations with experimental
observation study indicate that our aptamers bind to several amino
acid residues of the receptor-binding domain of the SARS-CoV-2 S protein.[12]A reported simulation study indicates
that the cytosine base at
53 position, guanine base at 54 position, and adenine base at 66 position
of the aptamer form a network of hydrogen bonds with glutamine, lysine,
and tyrosine amino acids from receptor-binding domain of the SARS-CoV-2
S protein.[12] Similarly, the thymine base
at 41 position of the aptamer forms a network of hydrogen bonds with
threonine from the receptor-binding domain of the SARS-CoV-2 S protein.[12] Because of these antigen–aptamer interactions,
the aptamer became straight and the distance between the GNS and the
Rh-6G dye increased.To understand better whether 5′-Rh-6G
ends of DNA aptamers
are far from the GNS surface when specific antigen has been added,
we also performed a SERS experiment.[23−25] As reported in Figure B, in the presence
of spike antigen, we have not observed any Raman signal from Rh-6G
conjugated ss DNA aptamer-attached GNSs. The observed SERS data clearly
indicate that Rh-6G in ss DNA aptamer is not adsorbed onto the GNS
surface after aptamer binds with spike antigen and that the distance
between Rh-6G and GNS is several nanometers. As a result, we have
not observed any SERS signal.In last few months, the FDA has
authorized antigen tests for COVID-19infection.[2] Our experimental data demonstrated
that distance-dependent NSET can be used to detect the same virus
antigens within 10 min of experimental time. For finding the limit
of detection (LOD) of the reported distance-dependent NSET assay,
we have determined the NSET intensity change in the presence of different
amounts of spike antigen. As shown in Figure C, the distance-dependent NSET assay can
recognize COVID-19-specific antigen even at the concentration of 100
fg/mL. As reported in Figure D, the log of NSET intensity difference (intensity after and
before COVID-19spike antigen) varies linearly with the log of the
concentration of COVID-19spike antigen. We used eq for finding the LOD for the distance-dependent
NSET assay.[16−25]In our experiment
the standard deviation of the blank (σ)
has been measured in the absence of antigen. The slope of the calibration
curve (S) has been calculated from the linear curve
reported in Figure D. The LOD for the distance-dependent NSET assay has been determined
to be ∼130 fg/mL for spike antigen.Selectivity of the
5′-Rh-6G conjugated DNA-attached GNS-based
distance-dependent NSET assay has been demonstrated using flu virus
antigen and rotavirus antigen separately. As shown in Figure A, we have not observed any
distance-dependent NSET intensity variation for flu or rotavirus antigen,
although we have used 100 pg/mL antigen. On the other hand, excellent
distance-dependent NSET intensity variation can be noted when only
10 pg/mL spike antigen has been added. The above experimental data
clearly indicate that the NSET assay can be used for specific recognition
of SARS-CoV-2spike recombinant antigen.As shown in Figure C, spike protein-specific
DNA conjugated GNS-based NSET diagnosis
of virus is based on the binding affinity of virus spike protein and
aptamer. As reported in Figures B–D and S2C in the
Supporting Information, because of the above interaction, the distance-dependent
NSET intensity enhances abruptly. The reported distance-dependent
NSET intensity variation has been used for the detection of the virus.
Because the size of the virus (120–160 nm) is much greater
than that of the GNS, electron microscopy images reported in Figures B and S2A,B in the Supporting Information show that
several aptamer-attached GNSs are bound on the virus. To understand
better whether 5′-Rh-6G ends of ss DNA aptamers are far from
the GNS surface in the presence of virus, we have measured Raman signal
with or without virus addition. As reported in Figure S2D in the Supporting Information, no Raman signal
has been observed from Rh-6G conjugated ss DNA aptamer-attached GNS
when viruses are present. The observed SERS data clearly indicate
that Rh-6G in ss DNA aptamers are not adsorbed on the GNS surface
after aptamer binds with the virus.
Figure 3
(A) SEM image of pseudo baculovirus-attached
GNS. (B) How the fluorescence
spectra from Rh-6G conjugated DNA aptamer-attached GNS varies when
different amounts of virus are added. (C) Plot shows how the log of
(fluorescence intensity difference in the presence and absence of
baculovirus) varies with the log of (concentration of baculovirus).
(D) Fluorescence image of pseudo baculovirus when they are attached
with Rh-6G conjugated DNA aptamer bound GNS.
(A) SEM image of pseudo baculovirus-attached
GNS. (B) How the fluorescence
spectra from Rh-6G conjugated DNA aptamer-attached GNS varies when
different amounts of virus are added. (C) Plot shows how the log of
(fluorescence intensity difference in the presence and absence of
baculovirus) varies with the log of (concentration of baculovirus).
(D) Fluorescence image of pseudo baculovirus when they are attached
with Rh-6G conjugated DNA aptamer bound GNS.Our experimental data indicate that distance-dependent NSET-based
virus diagnosis can be performed within 10 min using the spike. To
understand whether 5′-Rh-6G conjugated DNA-attached GNSs are
bound onto the virus surface, we have also performed a fluorescence
imaging experiment.As reported in Figure D, we can clearly see the red color image
from the virus-attached
nanosystem, which indicates that Rh-6G conjugated ss DNA-attached
GNS bound virus and Rh-6G are far from the GNS surface.Sensitivity
of the distance-dependent NSET assay for specific virus
detection has been determined by varying the virus amount from 10
to 500 virus/mL. As shown in Figure B, distance-dependent NSET assay has the capability
to identify coronavirus even at the 10 virus/mL concentration level.
As reported in Figure C, the log of NSET intensity difference (intensity before and after
virus addition) varies linearly with the log of the concentration
of the virus. Using the linear curve reported in Figure F and eq , the LOD for distance-dependent NSET assay
has been determined to be ∼8 virus/mL.To understand
whether the Rh-6G conjugated spike protein-specific
DNA aptamer-attached GNS-based NSET assay can be used for the detection
of COVID-19-specific antigen or virus, we have performed an experiment
using antigen or virus-infected artificial nasal mucus fluid samples.
Artificial nasal mucus fluid was purchased from Biochemazone, Canada,
and the nasal matrix was infected by adding different concentrations
of COVID-19-specific antigen or virus, separately. As shown in Figure A, we have not observed
NSET intensity change in the presence of only nasal matrix or nasal
matrix infected with flu virus antigen. On the other hand, as reported
in Figure B, the Rh-6G
conjugated spike protein-specific DNA aptamer-attached GNS-based NSET
assay has the capability to detect COVID-19-specific antigen even
in the concentration of 100 fg/mL. Similarly, as reported in Figure C, the Rh-6G conjugated
spike protein-specific DNA aptamer-attached GNS-based NSET assay has
the capability to detect virus even in the concentration of 20 virus/mL.
Figure 4
(A) Fluorescence
spectra from Rh-6G conjugated spike protein-specific
DNA aptamer-attached GNS in the presence of only buffer, only artificial
nasal matrix, and artificial nasal matrix infected with flu virus
antigen (100 fg/mL). (B) Fluorescence spectra from Rh-6G conjugated
spike protein-specific DNA aptamer-attached GNS in the presence of
artificial nasal matrix infected with SARS-CoV-2 spike recombinant
antigen (100 fg/mL and 300 fg/mL). (C) Fluorescence spectra from Rh-6G
conjugated spike protein-specific DNA aptamer-attached GNS in the
presence of artificial nasal matrix infected with pseudo baculovirus
(20 virus particle/mL and 100 virus particle/mL)
(A) Fluorescence
spectra from Rh-6G conjugated spike protein-specific
DNA aptamer-attached GNS in the presence of only buffer, only artificial
nasal matrix, and artificial nasal matrix infected with flu virus
antigen (100 fg/mL). (B) Fluorescence spectra from Rh-6G conjugated
spike protein-specific DNA aptamer-attached GNS in the presence of
artificial nasal matrix infected with SARS-CoV-2spike recombinant
antigen (100 fg/mL and 300 fg/mL). (C) Fluorescence spectra from Rh-6G
conjugated spike protein-specific DNA aptamer-attached GNS in the
presence of artificial nasal matrix infected with pseudo baculovirus
(20 virus particle/mL and 100 virus particle/mL)Next, we have determined whether spike protein-specific ss DNA
aptamer-attached GNS can be used to inhibit viral replication. For
this purpose, ACE2 expressing HEK293T cell line has been used.[27,28] In this experiment, we have used spike protein-specific ss DNA aptamer-attached
GNS without Rh-6G. We have discussed experimental details in the Supporting Information. Reported virus inactivation
data in Figure A–C
and S3 in the Supporting Information indicate
that ss DNA aptamer-attached GNS can block viral replication. 100%
inhibition efficiency was observed for ss DNA aptamer-attached GNSs
at the concentration of 100 ng/mL. On the other hand, less than 1%
inhibition efficiency was achieved for only GNSs or aptamer at the
same concentration level. The observed excellent inhibition efficiency
for aptamer-attached GNSs can be because of the binding of the aptamer-attached
GNSs to virus, resulting in the inability of the virus to bind with
ACE2.[27−30] Experimental data shown in Figure B indicate that aptamer-attached GNS can destroy the
lipid membrane of pseudo baculovirus, so that the virus particle collapses,[27−30] and as a result, it stops spreading.
Figure 5
(A) Fluorescence image
showing strong green fluorescent protein
expression from target cells when spike protein-specific ss DNA aptamer-attached
GNS is absent. (B) SEM image indicates damage of virus lipid membrane
of pseudo baculovirus, when virus and bioconjugated nanoparticles
are incubated for an hour. Inserted TEM image also indicates the same.
(C) Inhibition efficiency variation when only buffer (Mock), only
GNS, 100 ng/mL spike protein-specific ss DNA aptamer only, and 100
ng/mL spike protein-specific ss DNA aptamer-attached GNS have been
used. For this experiment, each of them were separately incubated
with virus for an hour.
(A) Fluorescence image
showing strong green fluorescent protein
expression from target cells when spike protein-specific ss DNA aptamer-attached
GNS is absent. (B) SEM image indicates damage of virus lipid membrane
of pseudo baculovirus, when virus and bioconjugated nanoparticles
are incubated for an hour. Inserted TEM image also indicates the same.
(C) Inhibition efficiency variation when only buffer (Mock), only
GNS, 100 ng/mL spike protein-specific ss DNA aptamer only, and 100
ng/mL spike protein-specific ss DNA aptamer-attached GNS have been
used. For this experiment, each of them were separately incubated
with virus for an hour.In conclusion, in this
work we report that spike protein-specific
aptamer-attached GNSs can be used for detection and inactivation of
corona virus. Our finding indicates that rhodamine 6G (Rh-6G) dye
conjugated DNA aptamer-attached GNS-based distance-dependent NSET
has the capability to detect spike antigen or virus itself very rapidly,
and results can be obtained in less than 10 min. Furthermore, the
NSET assay is highly sensitive where LOD as low as 130 fg/mL can be
achieved for SARS-CoV-2spike recombinant antigen, and in the case
of virus, the LOD is only 8 particles/mL. Finally, we demonstrate
that 100% virus inhibition efficiency for aptamer-attached GNSs occurs via blocking the cell attachment process and damage of the
lipid membrane. Although reported experimental data indicate that
the aptamer conjugated GNSs have the capability for diagnosis and
inhibition of corona virus, we are in the infancy of this research.
In the next phase, we plan to move beyond the phase of demonstrations
in the laboratory and find a way to move toward clinical applications.
Authors: Daniel Wrapp; Nianshuang Wang; Kizzmekia S Corbett; Jory A Goldsmith; Ching-Lin Hsieh; Olubukola Abiona; Barney S Graham; Jason S McLellan Journal: Science Date: 2020-02-19 Impact factor: 47.728
Authors: Linda J Carter; Linda V Garner; Jeffrey W Smoot; Yingzhu Li; Qiongqiong Zhou; Catherine J Saveson; Janet M Sasso; Anne C Gregg; Divya J Soares; Tiffany R Beskid; Susan R Jervey; Cynthia Liu Journal: ACS Cent Sci Date: 2020-04-30 Impact factor: 14.553
Authors: Alrayan Abass Albaz; Misbahuddin M Rafeeq; Ziaullah M Sain; Wael Abdullah Almutairi; Ali Saeed Alamri; Ahmed Hamdan Aloufi; Waleed Hassan Almalki; Mohammed Tarique Journal: AIMS Microbiol Date: 2021-10-12
Authors: Tomasz Wandtke; Ewelina Wędrowska; Marcin Szczur; Grzegorz Przybylski; Marek Libura; Piotr Kopiński Journal: Int J Mol Sci Date: 2022-01-26 Impact factor: 5.923